This article is more than 5 years old. Information may no longer be current.
CVD prevention remains major focus of ASPC congress
Click Here to Manage Email Alerts
Lipids, hypertension, lipoprotein(a), inflammation, atherogenesis and diet are some of the many topics that will be covered at this year’s American Society for Preventive Cardiology Congress on CVD Prevention.
The 3-day meeting will take place July 27 to 29 at the Hyatt Regency Tamaya Resort in Santa Ana Pueblo, New Mexico. Expert course sessions are scheduled for July 26 and 27.
“The group has expanded quite significantly over the past several years,” Seth J. Baum, MD, FASPC, chief medical officer of Excel Medical Clinical Trials; clinical affiliate professor of biomedical science at Florida Atlantic University in Boca Raton; and president and co-chair of the ASPC, told Cardiology Today. “We now have a very large presence on the West Coast. Appropriately, our broad membership wanted us to move the meeting around the country. This is our first year holding the congress outside of Florida, and I couldn’t be happier with the results.”
Sessions throughout the meeting target a wide range of medical professionals such as cardiologists, internists, family practitioners, endocrinologists, nurse practitioners and pharmacists.
“[We’re targeting] anybody who has a keen interest in preventing heart disease,” Baum said in an interview. “Fortunately, we are making inroads and the organization is growing and we are spreading the word about cardiovascular disease prevention.”
A major session of interest will be a keynote address from Sekar Kathiresan, MD, director of the Center for Genomic Medicine at Massachusetts General Hospital in Boston, director of the Cardiovascular Disease Initiative at the Broad Institute in Cambridge, Massachusetts, and associate professor of medicine at Harvard Medical School, who will discuss the role of genetics in CVD prevention.
Other conference highlights include the following:
- Sergio Fazio, MD, PhD, director of the Center for Preventive Cardiology and professor of medicine in the division of cardiovascular medicine at Oregon Health and Science University in Portland, will discuss the current and future status of preventive cardiology.
- Sessions on the updated hypertension guidelines by William Cushman, MD, professor of preventive medicine at University of Tennessee Health Science Center in Memphis and chief of the preventive medical section at VA Medical Center in Memphis; Keith C. Ferdinand, MD, FACC, FAHA, professor at Tulane University School of Medicine in New Orleans and a Cardiology Today Editorial Board Member, and Lynne Braun, PhD, CNP, professor in the departments of internal medicine and adult health and gerontological nursing at Rush University in Chicago.
- Barbara Howard, PhD, senior scientist at Georgetown University Medical Center in Washington, D.C., will focus on cardiometabolic disease in Native American individuals.
- Patrick M. Moriarty, MD, FACC, FACP, director of clinical pharmacology at University of Kansas Medical Center in Kansas City, and Fazio will present their viewpoints on lipoprotein(a).
“I want the attendees to walk away from this congress and be able to return to their practices and implement new strategies for cardiovascular disease prevention. I hope our meetings can help spread a vital message: ‘We have to start focusing on prevention, and we can effectively prevent cardiovascular disease by doing so,’” Baum said in an interview.
Cardiology Today and Healio.com staff will provide coverage from ASPC, including reports on the sessions described above and others, onsite video interviews and much more. For more information on the ASPC agenda and registration, visit www.aspconline.org. – by Darlene Dobkowski
For more information:
Seth J. Baum, MD, FASPC, can be reached at sjbaum@fpim.org.